Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Estaderma
WARNING LETTER
•Estaderma•November 1, 2025

Estaderma – FDA Warning Letter, Nov 1, 2025

Record Details

On November 3, 2025, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to Estaderma, a company based in South Korea. This action followed a review of their website, www.estaderma.com, which was found to be introducing unapproved and misbranded injectable botulinum toxin drug products, such as "Liztox 100u" and "Liztox," into interstate commerce.The primary violations stem from the products being unapproved new drugs under the Federal Food, Drug, and Cosmetic Act (FD&C Act) because they lack FDA clearance for safety and effectiveness. Additionally, they are deemed misbranded as prescription drugs intended for conditions not amenable to self-treatment, thereby failing to provide adequate directions for use. The FDA highlighted significant health risks associated with unapproved injectable drugs, including contamination and potential life-threatening complications.Estaderma is required to promptly cease offering all unapproved and misbranded drugs for sale to U.S. consumers. The company must submit a written response to the FDA within 15 working days, detailing the specific corrective actions taken to address these violations and prevent their recurrence, along with supporting documentation. Non-compliance could lead to further regulatory enforcement.

Company
Estaderma
Inspection date
November 1, 2025
Product type
Drugs
Office
Office of Drug Security, Integrity, and Response
Person
  • Sangeeta V. Chatterjee
View Company Profile

ID · 7219637f-12fe-4387-98f2-b6916bacc2bd

Violation Codes10
FD&C Act 301(a)FD&C Act 301(d)FD&C Act 503(b)FD&C Act 505(a)21.U.S.C. 331(a)21 U.S.C. 331(d)21 U.S.C. 353(b)21.U.S.C. 355(a)FD&C Act 201(g)21 U.S.C. 321(g)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Estaderma
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.